Test Code LABMDDNAONCO DNA OncoPlus PBBM
Specimen and Container/Tube
Specimen Type: Peripheral Blood / Bone Marrow Aspirates
Preferred Specimen: lavendar top (EDTA).
Other Acceptable Specimens: N/A
Volume
Preferred Volume: 3 mL
Minimum Volume: 3 mL
Specimen Stability
Blood and bone marrow aspirate specimens may be kept at room temperature for up to 6 hours following collection, or at 4°C for up to two weeks
Collection Instructions
Collect specimen per standard laboratory collection procedures.
Specimen Handling and Transport Instructions
UCM Onsite Instructions: Collect specimen per standard collection procedured and send to the laboratory immediately.
Turnaround Time
Turnaround times are relative to the time the specimen is received in the testing laboratory section.
STAT Turnaround Time: n/a
Routine Turnaround Time: ≤14 Days
Testing Schedule: M-F 7:00am-5:00pm
Clinical Indications
The OncoPlus panel is a universal cancer mutation, next generation sequencing (NGS) assay that has the capability to cover more than 1,005 cancer-related genes, of which 168 genes are clinically reported, for personalized assessments of both solid tumors and hematological malignancies. Additional reportable features include tumor mutational burden (TMB), microsatellite stability status, and copy number alterations.
Test Components
Genes analyzed for mutations and insertions/deletions (168): ABL1, AKT1, ALK, APC, ARID1A, ARID2, ASXL1, ATM, ATR, ATRX, AXL, B2M, BAP1, BCOR, BCORL1, BIRC3, BLM, BRAF, BRCA1, BRCA2, BTK, CALR, CBL, CBLB, CCND1, CCND2, CCND3, CCNE1, CD274, CDH1, CDK4, CDK6, CDK12, CDKN2A, CEBPA, CHEK1, CHEK2, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUX1, CXCR4, DAXX, DDR2, DDX3X, DDX41, DICER1, DNMT3A, EGFR, ELOC, EP300, EPHA3, EPHA5, ERBB2, ERBB3, ERBB4, ERCC3, ESR1, ETV6, EZH2, FANCA, FAT3, FBXW7, FGFR1, FGFR2, FGFR3, FH, FLT3, FOXL2, GATA1, GATA2, GNA11, GNAQ, GNAS, GRIN2A, H3-3A, H3C2, H3C3, HNF1A, HRAS, IDH1, IDH2, IKZF1, ITPKB, JAK2, KDM6A, KDR, KEAP1, KIT, KMT2A, KRAS, MAP2K1, MAPK1, MDM2, MET, MEN1, MLH1, MLH3, MPL, MRE11, MSH2, MSH6, MTOR, MYC, MYCN, MYD88, NBN, NF1, NF2, NFE2L2, NOTCH1, NOTCH2, NPM1, NRAS, NTRK1, NTRK2, NTRK3, PALB2, PAX5, PBRM1, PDGFRA, PDGFRB, PHF6, PIK3CA, PIK3CB, PIK3R1, PLCG2, POLE, POT1, PPP2R1A, PTCH1, PTEN, PTPN11, RAD21, RAD50, RAD51, RB1, RET, ROS1, RUNX1, SDHB, SDHC, SDHD, SETBP1, SETD2, SF3B1, SMAD4, SMARCB1, SMC1A, SMC3, SMO, SRSF2, STAG2, STAT3, STAT5B, STK11, TERT, TET2, TP53, TRAF7, TSC1, TSC2, U2AF1, VHL, WT1, ZRSR2
Genes analyzed for copy number variations (145 gene subset): ABL1, AKT1, ALK, APC, ARID1A, ARID2, ASXL1, ATM, ATR, AXL, B2M, BAP1, BIRC3, BLM, BRAF, BRCA1, BRCA2, CALR, CBL, CBLB, CCND1, CCND2, CCND3, CCNE1, CD274, CDH1, CDK4, CDK6, CDKN2A, CEBPA, CHEK1, CHEK2, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUX1, CXCR4, DAXX, DDR2, DDX41, DICER1, DNMT3A, EGFR, EP300, EPHA3, EPHA5, ERBB2, ERBB3, ERBB4, ERCC3, ESR1, ETV6, EZH2, FANCA, FAT3, FBXW7, FGFR1, FGFR2, FGFR3, FH, FLT3, FOXL2, GATA2, GNA11, GNAQ, GNAS, GRIN2A, H3-3A, H3C2, H3C3, HNF1A, HRAS, IDH1, IDH2, IKZF1, ITPKB, JAK2, KDR, KIT, KMT2A, KRAS, MAP2K1, MAPK1, MDM2, MET, MLH1, MLH3, MPL, MRE11, MSH2, MSH6, MTOR, MYC, MYCN, MYD88, NBN, NF1, NF2, NFE2L2, NOTCH1, NOTCH2, NPM1, NRAS, PALB2, PBRM1, PDGFRA, PDGFRB, PIK3CA, PIK3CB, PIK3R1, PLCG2, POLE, POT1, PPP2R1A, PTCH1, PTEN, PTPN11, RAD21, RAD51, RB1, RET, RUNX1, SDHB, SDHC, SDHD, SETBP1, SF3B1, SMAD4, SMARCB1, SMC3, SMO, SRSF2, STAT3, STAT5B, STK11, TERT, TET2, TP53, TSC1, TSC2, U2AF1, VHL, WT1
Genes analyzed for fusions/translocations (3): ALK, RET, and ROS1
CPT Codes
81450
Methodology
The test procedure involves DNA extraction and quantity/quality assessment, fragmentation and library preparation, followed by pooled capture targeting the desired genomic loci. Next generation sequencing (NGS) is performed on the Illumina platform and downstream analysis for quality control and detection of mutations is performed via custom-design bioinformatics pipelines on a HIPAA-compliant high performance computing system within the Center for Research Informatics (CRI).
Synonyms/Key Search Words
CNV, copy number, cancer, mutation, panel, NGS, NextGen, Sequencing, Gene